The company has a presence in more than 60 countries encompassing Africa, Central America and Southeast Asia and expanding its presence gradually in more countries. Company has also got many product registrations in countries like East and West Africa, South East Asia and Latin America. Exports have increased from 11% of the total sales in FY11 to 60% in FY20
For the next phase of growth, company is building a strong portfolio in lifestyle and chronic segment especially women healthcare and dermatology to complement its strong presence in acute segment.Further to expand global footprint and tap the export opportunities we are considering a proposal to set up a USFDA facility in Gujarat.